PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+6.95%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.74B
AUM Growth
+$1.74B
(-5%)
Cap. Flow
-$150M
Cap. Flow
% of AUM
-8.63%
Top 10 Holdings %
Top 10 Hldgs %
50.56%
Holding
88
New
12
Increased
13
Reduced
23
Closed
11
Top Buys
| 1 |
Inspire Medical Systems
INSP
|
$20.8M |
| 2 |
Acadia Healthcare
ACHC
|
$16.9M |
| 3 |
Ascendis Pharma
ASND
|
$13.6M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$12M |
| 5 |
Waters Corp
WAT
|
$11M |
Top Sells
| 1 |
Centene
CNC
|
$39.7M |
| 2 |
DexCom
DXCM
|
$26.2M |
| 3 |
Edwards Lifesciences
EW
|
$23.1M |
| 4 |
Arcellx
ACLX
|
$21M |
| 5 |
Boston Scientific
BSX
|
$20.1M |
Sector Composition
| 1 | Healthcare | 97.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $265M | 14.99% | 298,643 | – | – |
|
2
Tenet Healthcare
THC
$16.3B
| $98M | 5.55% | 589,409 | – | – |
|
3
Cytokinetics
CYTK
$4.23B
| $92.8M | 5.26% | 1,757,192 | – | – |
|
4
AbbVie
ABBV
$372B
| $79.8M | 4.52% | 403,861 | – | – |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $69.2M | 3.92% | 148,852 | – | – |
|
6
Intuitive Surgical
ISRG
$170B
| $67.5M | 3.82% | 137,327 | – | – |
|
7
Merck
MRK
$210B
| $61.6M | 3.49% | 542,811 -53,450 | -9% | -$6.07M |
|
8
HCA Healthcare
HCA
$94.5B
| $50.7M | 2.88% | 124,840 | – | – |
|
9
Universal Health Services
UHS
$11.6B
| $49M | 2.78% | 213,983 | – | – |
|
10
McKesson
MCK
$85.4B
| $48.2M | 2.73% | 97,498 | – | – |
|
11
argenx
ARGX
$43.6B
| $47.1M | 2.67% | 86,832 | – | – |
|
12
UnitedHealth
UNH
$281B
| $44.2M | 2.5% | 75,588 +6,150 | +9% | +$3.6M |
|
|
13
Acadia Healthcare
ACHC
$2.12B
| $43.5M | 2.47% | 686,150 +265,986 | +63% | +$16.9M |
|
14
Axsome Therapeutics
AXSM
$6.05B
| $42M | 2.38% | 467,427 | – | – |
|
15
Thermo Fisher Scientific
TMO
$186B
| $36.1M | 2.05% | 58,433 -5,217 | -8% | -$3.23M |
|
16
Danaher
DHR
$147B
| $34.9M | 1.98% | 125,515 | – | – |
|
17
Icon
ICLR
$13.8B
| $33.5M | 1.9% | 116,532 | – | – |
|
18
Penumbra
PEN
$10.6B
| $32.3M | 1.83% | 166,261 -18,850 | -10% | -$3.66M |
|
19
Humana
HUM
$36.5B
| $32.3M | 1.83% | 101,954 -23,386 | -19% | -$7.41M |
|
20
Elevance Health
ELV
$71.8B
| $29.3M | 1.66% | 56,441 +1,191 | +2% | +$619K |
|
21
Amgen
AMGN
$155B
| $29.1M | 1.65% | 90,297 +9,263 | +11% | +$2.98M |
|
22
IQVIA
IQV
$32.4B
| $26.5M | 1.5% | 111,854 | – | – |
|
|
23
Edwards Lifesciences
EW
$47.8B
| $25.8M | 1.46% | 390,863 -349,397 | -47% | -$23.1M |
|
24
Becton Dickinson
BDX
$55.3B
| $24.5M | 1.39% | 101,680 -29,698 | -23% | -$7.16M |
|
25
Stryker
SYK
$150B
| $24.2M | 1.37% | 67,014 -47,283 | -41% | -$17.1M |
|